Fang, P., Eng, W., Fu, H., Mozley, P. D., Yang, S., He, H., Yu, C. (2025). Phase I/II trial of
            <sup>177</sup>
            Lu-NYM032 for progressive metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e17040